The use of Bayesian networks for nanoparticle risk forecasting: model formulation and baseline evaluation
Eric S Money1, Kenneth H Reckhow, Mark R Wiesner
1Center for the Environmental Implications of NanoTechnology (CEINT), P.O. Box 90287, Duke University, Durham, NC 27708-0287, USA.
Abstract:
We describe the use of Bayesian networks as a tool for nanomaterial risk forecasting and develop a baseline probabilistic model that incorporates nanoparticle specific characteristics and environmental parameters, along with elements of exposure potential, hazard, and risk related to nanomaterials. The baseline model, FINE (Forecasting the Impacts of Nanomaterials in the Environment), was developed using expert elicitation techniques. The Bayesian nature of FINE allows for updating as new data become available, a critical feature for forecasting risk in the context of nanomaterials. The specific case of silver nanoparticles (AgNPs) in aquatic environments is presented here (FINE(AgNP)). The results of this study show that Bayesian networks provide a robust method for formally incorporating expert judgments into a probabilistic measure of exposure and risk to nanoparticles, particularly when other knowledge bases may be lacking. The model is easily adapted and updated as additional experimental data and other information on nanoparticle behavior in the environment become available. The baseline model suggests that, within the bounds of uncertainty as currently quantified, nanosilver may pose the greatest potential risk as these particles accumulate in aquatic sediments.
Related Concept Videos
Model Approaches for Pharmacokinetic Data: Distributed Parameter Models
The distributed parameter models are specifically designed to account for variations and differences in some drug classes. This model is particularly useful for assessing regional concentrations of anticancer or...
Impact of Pharmacokinetic–Pharmacodynamic Models: Regulatory Decisions
Pharmacokinetic Models: Comparison and Selection Criterion
Physiological models take a detailed approach by considering specific molecular processes. They can predict drug distribution, metabolism, and elimination changes, providing a comprehensive understanding of how drugs interact with the body.
Analysis Methods of Pharmacokinetic Data: Model and Model-Independent Approaches
The model approach uses mathematical models to describe changes in drug concentration over time. Pharmacokinetic models help characterize drug behavior in patients, predict drug concentration in the body fluids, calculate optimum dosage regimens, and evaluate the risk of toxicity. However, ensuring that the model fits the experimental data accurately...
Pharmacokinetic Models: Overview
There are three primary types of models: empirical, compartment, and physiological. Empirical models, with minimal assumptions,...
Pharmacodynamic Models: Overview
